Portal de Periódicos da CAPES

Pityriasis rosea‐like arranged eruption after infliximab therapy in a patient with psoriasis vulgaris

2014; Wiley; Volume: 41; Issue: 4 Linguagem: Inglês

10.1111/1346-8138.12445

1346-8138

Tsutomu Ohtsuka,

Cytomegalovirus and herpesvirus research

The Journal of DermatologyVolume 41, Issue 4 p. 354-355 Letter to the Editor Pityriasis rosea-like arranged eruption after infliximab therapy in a patient with psoriasis vulgaris Tsutomu Ohtsuka, Corresponding Author Tsutomu Ohtsuka Department of Dermatology, International University of Health and Welfare Hospital, Nasushiobara, JapanCorrespondence: Tsutomu Ohtsuka, M.D., Ph.D., Department of Dermatology, International University of Health and Welfare Hospital, 537-3 Iguchi Nasushiobara, Tochigi 329-2763, Japan. Email: [email protected]Search for more papers by this author Tsutomu Ohtsuka, Corresponding Author Tsutomu Ohtsuka Department of Dermatology, International University of Health and Welfare Hospital, Nasushiobara, JapanCorrespondence: Tsutomu Ohtsuka, M.D., Ph.D., Department of Dermatology, International University of Health and Welfare Hospital, 537-3 Iguchi Nasushiobara, Tochigi 329-2763, Japan. Email: [email protected]Search for more papers by this author First published: 12 March 2014 https://doi.org/10.1111/1346-8138.12445Citations: 4Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1Barker J, Hoffmann M, Wozel G et al. Efficacy and safety of infliximab vs. methotrexate in patients with moderate-to-severe plaque psoriasis: results of an open-label, active-controlled, randomized trial (RESTORE1). Br J Dermatol 2011; 165: 1109–1117. 10.1111/j.1365-2133.2011.10615.x CASPubMedWeb of Science®Google Scholar 2Shmidt E, Wetter DA, Ferguson SB, Pittelkow MR. Psoriasis and palmoplantar pustulosis associated with tumor necrosis factor-α inhibitors: the Mayo Clinic experience, 1998 to 2010. J Am Acad Dermatol 2012; 67: e179–e185. 10.1016/j.jaad.2011.05.038 PubMedWeb of Science®Google Scholar 3Ko JM, Gottlieb AB, Kerbleski JF. Induction and exacerbation of psoriasis with TNF-blockade therapy: a review and analysis of 127 cases. J Dermatolog Treat 2009; 20: 100–108. 10.1080/09546630802441234 CASPubMedWeb of Science®Google Scholar 4Guarneri C, Polimeni G, Nunnari G. Pityriasis rosea during etanercept therapy. Eur Rev Med Pharmacol Sci 2009; 13: 383–387. CASPubMedWeb of Science®Google Scholar Citing Literature Volume41, Issue4April 2014Pages 354-355 ReferencesRelatedInformation